Near Real-Time Surveillance to Assess the Safety of the 9-Valent Human Papillomavirus Vaccine
James G. Donahue(Brigham and Women's Hospital), Edward A. Belongia(Marshfield Clinic), David L. McClure(Marshfield Clinic), Elizabeth Vickers(Marshfield Clinic), Lisa A. Jackson(Kaiser Permanente Washington Health Research Institute), Kayla E. Hanson(Marshfield Clinic), Rulin C. Hechter(Kaiser Permanente), Nicola P. Klein, Jennifer C. Nelson(Kaiser Permanente Washington Health Research Institute), Burney A. Kieke(Marshfield Clinic), Edwin Lewis(Kaiser Permanente), Eric Weintraub, Frank DeStefano(Abbott Fund), Allison L. Naleway(Centers for Disease Control and Prevention), Julianne Gee, Matthew F. Daley(Kaiser Permanente)
Cited by 48
Related Papers
Antigenic and Genetic Characteristics of Swine-Origin 2009 A(H1N1) Influenza Viruses Circulating in Humans
|Science|2009|2.5k
Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis
|The Lancet Infectious Diseases|2011|1.8k
Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents
|New England Journal of Medicine|2021|937
Effects of the COVID-19 Pandemic on Routine Pediatric Vaccine Ordering and Administration — United States, 2020
|MMWR Morbidity and Mortality Weekly Report|2020|720
Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase
|New England Journal of Medicine|2021|661